Announcement on Voluntary Disclosure of Approval by the Therapeutic Goods Administration of Australia for the Marketing of Orelabrutinib

Announcement on Voluntary Disclosure of Approval by the Therapeutic Goods Administration of Australia for the Marketing of Orelabrutinib

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment